Editor - Erin Eun-Young Ahn | University of South Alabama Mitche | 19327
ISSN: 2476-2253

Journal of Cancer Diagnosis
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

11th World Congress on Breast Cancer

Berlin, Germany
Indexed In
  • Google Scholar
  • RefSeek
  • Hamdard University
  • Publons
Share This Page

Erin Eun-Young Ahn

Erin Eun-Young Ahn
Erin Eun-Young Ahn
Associate Professor
Mitchell Cancer Institute
University of South Alabama
University of South Alabama Mitchell Cancer Institute


Dr. Ahn earned her Ph.D. from the University of Alabama at Birmingham, USA, after completing her undergraduate work in Seoul National University, South Korea. She did her postdoctoral research in Scripps Research Institute and University of California San Diego with special interests in molecular mechanisms of leukemia and roles of RNA splicing. After serving as Assistant Project Scientist at the Moores Cancer Center of the University of California San Diego, Dr. Ahn joined Mitchell Cancer Institute, University of South Alabama as an Assistant Professor in 2012. She heads a lab that is interested in transcriptional control, RNA splicing and non-coding RNA regulation in cancer development and progression, with the goal of identifying novel drug targets for cancer therapy. She is the recipient of numerous professional awards, including international awards for research in leukemia and allied conditions from Lady TATA Memorial Trust.

Research Interest

Mechanisms of RNA splicing and epigenetic controls,Roles of non-coding RNAs in cancer development and progression,Regulation of transcription factors in leukemia and breast cancer,Identification of novel targets for cancer therapy.

Global Speakers in the subject

Global Experts in the subject